Search research articles
Contact Us
Filters
Showing results (11-20 of 117) with videos related to
Page
of 12
Sort By:
Current Hematologic Malignancy Reports
|
February 25, 2017
CARs in the Lead Against Multiple Myeloma
Maria Ormhøj, Felipe Bedoya, Matthew J Frigault, et al.
Hematological Oncology
|
December 17, 2024
Post-CAR T-Cell Therapy Failure Metabolic Parameters Predict Survival and Response in Large B-Cell Lymphoma
Hazim S Ababneh, Matthew J Frigault, Andrea K Ng, et al.
Hematological Oncology
|
December 16, 2023
Radiation therapy as bridging and salvage strategy among patients with secondary central nervous system lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapy
Hazim S Ababneh, Matthew J Frigault, Andrea K Ng, et al.
Journal for Immunotherapy of Cancer
|
December 22, 2022
Dose-response correlation for CAR-T cells: a systematic review of clinical studies
Anand Rotte, Matthew J Frigault, Ayub Ansari, et al.
The New England Journal of Medicine
|
October 13, 2021
Case 31-2021: A 21-Year-Old Man with Sore Throat, Epistaxis, and Oropharyngeal Petechiae
Hanno Hock, Hillary R Kelly, Eric A Meyerowitz, et al.
Journal of the American College of Cardiology
|
May 16, 2020
Reply: Cardiac Events Associated With Chimeric Antigen Receptor T Cells (CAR-T): A VigiBase Perspective
Raza M Alvi, Michael G Fradley, Matthew J Frigault, et al.
American Journal of Hematology
|
June 11, 2024
Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy
Hazim S Ababneh, Andrea K Ng, Matthew J Frigault, et al.
Transplantation and Cellular Therapy
|
February 27, 2024
Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy
P Connor Johnson, Isabel Neckermann, Hossein Sadrzadeh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 24, 2026
Outcomes of combined bispecific antibody and radiation therapy in relapsed/refractory hematologic malignancies
Hazim S Ababneh, Andrew J Yee, Noopur S Raje, et al.
The Journal of Infectious Diseases
|
December 20, 2021
False-Positive Human Immunodeficiency Virus Test Results in Patients Receiving Lentivirus-Based Chimeric Antigen Receptor T-Cell Therapy: Case Report, Review of the Literature, and Proposed Recommendations
Julian A Villalba, Marcela V Maus, Matthew J Frigault, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 117) with videos related to
Sort By:
Page
of 12
Current Hematologic Malignancy Reports
|
February 25, 2017
CARs in the Lead Against Multiple Myeloma
Maria Ormhøj, Felipe Bedoya, Matthew J Frigault, et al.
Hematological Oncology
|
December 17, 2024
Post-CAR T-Cell Therapy Failure Metabolic Parameters Predict Survival and Response in Large B-Cell Lymphoma
Hazim S Ababneh, Matthew J Frigault, Andrea K Ng, et al.
Hematological Oncology
|
December 16, 2023
Radiation therapy as bridging and salvage strategy among patients with secondary central nervous system lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapy
Hazim S Ababneh, Matthew J Frigault, Andrea K Ng, et al.
Journal for Immunotherapy of Cancer
|
December 22, 2022
Dose-response correlation for CAR-T cells: a systematic review of clinical studies
Anand Rotte, Matthew J Frigault, Ayub Ansari, et al.
The New England Journal of Medicine
|
October 13, 2021
Case 31-2021: A 21-Year-Old Man with Sore Throat, Epistaxis, and Oropharyngeal Petechiae
Hanno Hock, Hillary R Kelly, Eric A Meyerowitz, et al.
Journal of the American College of Cardiology
|
May 16, 2020
Reply: Cardiac Events Associated With Chimeric Antigen Receptor T Cells (CAR-T): A VigiBase Perspective
Raza M Alvi, Michael G Fradley, Matthew J Frigault, et al.
American Journal of Hematology
|
June 11, 2024
Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy
Hazim S Ababneh, Andrea K Ng, Matthew J Frigault, et al.
Transplantation and Cellular Therapy
|
February 27, 2024
Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy
P Connor Johnson, Isabel Neckermann, Hossein Sadrzadeh, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 24, 2026
Outcomes of combined bispecific antibody and radiation therapy in relapsed/refractory hematologic malignancies
Hazim S Ababneh, Andrew J Yee, Noopur S Raje, et al.
The Journal of Infectious Diseases
|
December 20, 2021
False-Positive Human Immunodeficiency Virus Test Results in Patients Receiving Lentivirus-Based Chimeric Antigen Receptor T-Cell Therapy: Case Report, Review of the Literature, and Proposed Recommendations
Julian A Villalba, Marcela V Maus, Matthew J Frigault, et al.
Page
of 12